chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 10 year old female who on 13-FEB-2002 was vaccinated with the first dose of MMR II (HSA) (lot number not reported) and on 11-AUG-2004 was vaccinated with the second dose of MMR II (HSA) (lot number not reported). On 30-NOV-2009, the patient experienced mumps. The patient was afebrile. On 02-DEC-2009, lab data revealed that IgM <1:10, IgG 1.73 and serum amylase 50. On the same date, the patient was diagnosed. The patient had parotitis. Follow-up information was received which reported that the patient on 15-JAN-2010 developed mumps. On 17-JAN-2010, the patient was diagnosed. The patient had parotitis. No laboratory tests were conducted. At the time of the report, the patient's status was unknown. No further information is available.
Patient admitted for other reasons than COVID, she was test asymptomatically for discharge back to the nursing home that she lives at
High temp of 104 F per ear, this was noted @ 8pm. Noticed spots appearing on face and back @ this time also. She ran a temp until 12/20/09 PM. Spots are on most of her body at this time. She was taken to family Dr. Monday AM and was instructed to this website. Currently she still has spots but they are more faint now, she is afebrile, and no s/s of itchiness.
Arm hurt from shoulder to elbow. Went to pharmacy 2 wks later, was referred to primary doctor. 2 wks later still having problem. Was advised to use pensaid ointment. That helped some, but still have limited strength even today .
Slight headache 1 day, extreme fatigue 2nd day, arm pain 10 days and arm had a circular red circle around the injection sight for 10 days, some shortness of breath.   Had Covid-19 virus 12/17/2020.
She states that she and a few of her coworkers all tested positive after they had already had the first dose of the Pfizer COVID 19 vaccination; She states that she and a few of her coworkers all tested positive after they had already had the first dose of the Pfizer COVID 19 vaccination; This is a spontaneous report from a contactable consumer or other non HCP. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, she and a few of her coworkers all tested positive on an unspecified date after they had already had the first dose of the Pfizer COVID 19 vaccination. She and one other coworker have both tested negative now. She would like to know if she needed to start the series over again or if she can receive her second dose of the vaccine today or not as she was due to take her second vaccination today but she was informed by her coworker that if you tested positive after getting the first dose, you were not supposed to get the second dose and patient was trying to figure it out. The patient underwent lab tests and procedures which included SARS-COV-2 test which was positive on an unspecified date; she and one other coworker have both tested negative now. The outcome of event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Headache 4 days Fever 4 days Chills 4 days Loose stools 2 days Abdominal blister rash ( post 7 days and it has crusted over and it slowly disappearing) Productive Cough 4 days (started on z-pack on 1/14/22) Raw throat 4 days (started on z-pack on 1/14/22) Slight shortness of breath 3 days Lymphedema 4 days. Nose Bleeds 4 days (right side only)
Information has been received from a 56 year old male patient referring to himself. No pertinent medical conditions and drug allergies were reported. On 03-SEP-2015, the patient was vaccinated with ZOSTAVAX for prevention of shingles (strength, dose, route, lot# and expiration date unknown). There was no concomitant medication reported. On 04-SEP-2015, the patient stated that he experienced a "bee-like sting" in this thigh the day after receiving ZOSTAVAX. He then experienced tingling, numbness and aching in the same leg. The reactions subsided on an unspecified date in September 2015. But then on 06-SEP-2015 the reactions reoccurred. He also had difficulty walking. At the time of reporting, he was still experiencing the numbness and tingling. The patient did not seek medical attention and no lab diagnostics studies were performed to the patient. The outcome of the events of aching reoccurred and difficulty walking was unknown. Causality between the events and ZOSTAVAX was not reported. Additional information has been requested.
lethargic; covid 19; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic) and COVID-19 (covid 19) in a 70-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 003K21-29) for COVID-19 prophylaxis.     Patient was tested Positive for COVID-19 in OCT or NOV 2022.  Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (1st dose with lot number 025J20-2A) on 06-Jan-2021, Moderna COVID-19 Vaccine (2nd dose with lot number 030L20A) on 03-Feb-2021 and Moderna COVID-19 Vaccine (3rd dose with lot number 939902) on 22-Sep-2021. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine.    On 07-Mar-2022, the patient received fourth dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargic) and COVID-19 (covid 19). At the time of the report, LETHARGY (lethargic) and COVID-19 (covid 19) had resolved.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   Treatment medication not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-735462 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735462:Husband case
Rash to bilateral buttocks and upper leg 2 days after first Rabies vaccine. Second vaccine given day prior. Pt told to take Benadryl prn.
(R) arm swelling, erythema and pain 24-48 hrs after injection - area involved 4 x 6"
Dr diagnosed cellulitis in left arm at injection site. Patient was given Duricef 125cc b/o x 5 days.
This is a spontaneous report from a RN referring to a 50 year old female who, 5 days post vax, on 7/28/1999, she experienced a 3cm X 4cm area of hives at the injection site. On 7/30/1999, the hives resolved. Some itching and redness remained. On 8/1/1999, symptoms were completely resolved. The most recent information, received on 8/5/1999, reports the condition of the pt is resolved.
arm started to get sore; Like the flu; Tired/feels ran down; Body aches especially in his back; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm started to get sore), INFLUENZA LIKE ILLNESS (Like the flu), FATIGUE (Tired/feels ran down), MYALGIA (Body aches especially in his back) and CHILLS (Chills) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Like the flu), FATIGUE (Tired/feels ran down), MYALGIA (Body aches especially in his back) and CHILLS (Chills). On 21-Jan-2021 at 10:00 AM, the patient experienced PAIN IN EXTREMITY (arm started to get sore). At the time of the report, PAIN IN EXTREMITY (arm started to get sore), INFLUENZA LIKE ILLNESS (Like the flu), FATIGUE (Tired/feels ran down) and MYALGIA (Body aches especially in his back) outcome was unknown and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Plans to see MD this pm. Had Td vaccine 9/6/02 had "hard knot" on 9/7/02. Began to be red and inflmaed on 9/8/02. Has 3 1/2" area of erythema on R deltoid area-c/o headache for past day.
Approximately 1 hr after receiving flu vaccine client began to experience chest tightness accompanied by cough. She fell asleep approximately 4 hrs after receiving the vaccine, still coughing with chest tightness. When she woke up 1 hr later her symptoms were gone and she felt better. No further symptoms have been experienced.
Pt received Rotateq 9/24/13 and started having bloody diarrhea two days later. We sent stool samples off and were positive for Shigella.
swelling under my arm, in the armpit; discomfort; lifting my arm above my shoulder without pain; This is a spontaneous report from a contactable consumer or other non hcp. A 29-years-old patient of an unspecified gender received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: FF8841), via an unspecified route of administration, administered in Arm Left on 15Oct2021 17:30 (at the age of 29-years-old) as dose 3 (booster), single for covid-19 immunisation, the patent also received influenza vaccine (FLU), via an unspecified route of administration from 15Oct2021 (Batch/Lot number was not reported) to 15Oct2021, at unspecified dose for immunization and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP), via an unspecified route of administration from 15Oct2021 (Batch/Lot number was not reported) to 15Oct2021, at unspecified dose for immunization. Medical history included Allergies: Sulfa based drugs and immunization. Concomitant medications included losartan, estradiol and spironolactone. The patient received first dose of BNT162B2 on 18Mar2021 at 02:30 PM (Batch/Lot No: EP7534, Location of injection: Arm Right) and received second dose on 08Apr2021 at 02:30 PM (batch/Lot No: EW0153, Location of injection: Arm Right) for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was tested for COVID-19 since the vaccination. On 16Oct2021 the patient experienced swelling under my arm, in the armpit, discomfort and lifting my arm above my shoulder without pain. The patient reported that the day after covid booster, woke with a large amount of swelling under arm, in the armpit. There was almost constant discomfort, and it prevents from letting the arm fully relax at the side or lifting the arm above shoulder without pain. The amount of swelling is fairly large, as when the patient looks into the mirror, armpit no longer has a concave profile. It is now convex. The patient had gotten 2 other vaccines that day. They were a Tdap and a flu shot. The swelling in armpit is on the left side, which is the same arm as where covid booster was administered and the flu shot, the Tdap shot was in my right arm, but the patient reported that might be mixing up which arms the flu and Tdap shots went into. The patient had not gone to the physician, because it had only been about 36-40 hours, and the swelling has gone down slightly (but not much). The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 10Sep2020 Date is approximate. The action taken in response to the events for influenza vaccine was not applicable, for diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid was not applicable. The outcome of all the events was not resolved. Follow-up attempts are completed. No further information is expected.
Patient is a 60-year-old female with a past medical history of of restrictive lung disease, Poland syndrome right side of the chest, 50% lung capacity at birth s/p multiple surgeries, left breast cancer in 2018 s/p lumpectomy/chemo/radiation, neuropathy presented to the ED with complaints of chest tightness and shortness of breath which started yesterday morning. She reports that she uses oxygen 3 L nasal cannula as needed at bedtime, her O2 sat was 93%, yesterday she was using the oxygen. She received her second dose of Covid vaccine yesterday, the symptoms worsened after that. She received DuoNeb, magnesium sulfate 2 g, Solu-Medrol 125 mg from ED. ED provider planned her discharge, patient states she has to come back after calling EMS since she is hard to breathe. Patient wants to currently she is resting in bed without any distress, O2 sat 96% on room air at the monitor. Her second EKG showed ventricular bigeminy. Troponin 0.012, 0.012.  2 D echo done on 4/29/2019 shows EF 58%, mild concentric LVH. Her BP was high while at ED, states usually normal.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Nausea-Severe
I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/23/2022 LATE EFFECT OF STROKE I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/23/2022 HTN (HYPERTENSION) I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/23/2022 SECONDARY HYPERCOAGULABLE STATE
Within 15 minutes I had a metallic taste in my mouth that lasted several hours.  I had heart palpitations for several days on and off.  My armed at the injection site swelled into a large oval and turned red.  It was hot and itchy for 10 days, when I returned to the pharmacy and had it evaluated.  The pharmacists said I must be allergic to something in the shot.  Therefore, I have not been able to receive a second shot.
Joint pain in the ankles; Muscle soreness in his calf; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain in the ankles) and MYALGIA (Muscle soreness in his calf) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and LANSOPRAZOLE (PREVACID).    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 17-Feb-2021, the patient experienced ARTHRALGIA (Joint pain in the ankles) and MYALGIA (Muscle soreness in his calf). At the time of the report, ARTHRALGIA (Joint pain in the ankles) and MYALGIA (Muscle soreness in his calf) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Numbness in neck and face on left side lasting for 3-4 days; now intermittent tingling in face and neck on left side; no facial droop
Patient describes increased heart rate, sweating, and high blood pressure. Symptoms stsrted later that day after vaccination and has had on off for few days after.
Upper left arm cellulitis with erythematous area about 20cm x 15cm, increased temp at site with palpation. Pneumovax administered on 1/27/2006. Pt started pegasys and ribavirin treatment same day for hepatitis C virus Pegasys injection site was right below abdomen.
Arm hurting/arm was sore; The pain ended up on like her shoulder blade and it's still sore like someone punched her; Now, its moving to the back of the neck area; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that:   A 53 years of age female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration on 23Mar2021 (At the age of 53 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The Patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration on unspecified date as dose 1, single for covid-19 immunisation. On an unspecified date in Mar2021, the patient had experienced arm hurting/arm was sore, pain ended up on her shoulder blade and for now pain moving to the back of the neck area. she states that it feels as though she has been punched in the area and she is concerned. At the time of reporting, the outcome of the events were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Has not received her second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received her second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received her second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received her second dose) outcome was unknown.            No concomitant medication were provided by the reporter No treatment medication were provided by the reporter   Reporter did not allow further contact
Narrative: Admission Date: September 13, 2021 Discharge Date: September 15, 2021 Discharge Type: Regular PRINCIPAL DIAGNOSIS: 1. Acute hypoxic respiratory failure ADDITIONAL DIAGNOSES: 1. Acute SARS-CoV-2 pneumonia. 2. Superimposed bacterial pneumonia 3. Prediabetes 4. History of pulmonary embolism and infarction 5. History of tuberculosis 6. History of tobacco use 7. Chronic sinusitis 8. Chronic post-traumatic stress disorder 9. Chronic insomnia PROCEDURES: 09/13/2021 CT angiogram of chest with contrast: Impression: 1) No radiographic evidence of pulmonary emboli. 2) Extensive interstitial infiltrates along with volume loss involving the right lung. HISTORY OF PRESENT ILLNESS: PATIENT is a 67 year-old male with a history of prediabetes, h/o PE with infarction, h/o TB, h/o tobacco use, chronic sinusitis, PTSD, and insomnia, who presented to the emergency department on 09/13/21 with complaint of persistent shortness of breath since being discharged from outside Hospital one week prior. He said the shortness of breath was mainly during exertion. He denied any fever, chills, increase in cough, abdominal symptoms, or urinary symptoms. He had tested positive for COVID-19 virus on 08/20/21, and was admitted to outside Hospital from 08/23-09/06/21. He received REGEN-COV (casirivimab & imdevimab monoclonal antibodies) on 08/23/21. He also received 5 days of IV remdesivir therapy from 08/24-08/28/21. He was discharged on 4 liters oxygen for home use. Of note, he had received one dose of Janssen COVID-19 vaccination on 04/09/21. In the ED on 09/13/21, a CT angiogram of the chest showed extensive right lung interstitial infiltrates, but no evidence of any pulmonary emboli. On ABG, pO2 was 73.9 on 4 liters oxygen. HOSPITAL COURSE: PATIENT was admitted to the Medical Step Down Unit on 09/13/21 for treatment of acute hypoxic respiratory failure, acute COVID-19 pneumonia with presumed superimposed bacterial pneumonia. He was placed on 6 liters of oxygen, and started on cefepime IV antibiotic. He was also treated with IV methylprednisolone, prn albuterol inhaler, and prn tylenol. His symptoms improved, and he was transferred to the general medical floor on 09/14/21. That day, he was successfully weaned to 4 liters, which was his home prescription. PATIENT was medically stable for discharge home on 09/15/21.
The first night I had mild flu symptoms and a headache. I had rash all over my body.
About a week after receiving the injection, the general area around the deltoid(?) injection site became itchy, warm, swollen. this lasted for approximately 4 - 5 days
Patient developed headache, sore throat, body aches, and significant redness of eyes a few hours after receiving the high dose flu vaccine. Patient was treated at outpatient clinic and it was recommended that patient take otc antihistamine.
Petechaie and bruising of left cheek, around eye and left ear, + swelling of left cheek, some petechaie and bruising around right eye and cheek but much less than left. Vaccine injection sites have no swelling or bruising. Pt is happy and in no acute distress.
She had taken 4 of the 5 Pfizer Covid Vaccines but each time she takes it she gets a very fast heartbeat and lasts for quite a while, sometime months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing); "gluten allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, She had taken 4 of the 5 Pfizer Covid Vaccines but each time she takes it she gets a very fast heartbeat and lasts for quite a while), for Covid-19 immunization, reaction(s): "very fast heartbeat"; Bnt162b2 (DOSE 2, SINGLE, She had taken 4 of the 5 Pfizer Covid Vaccines but each time she takes it she gets a very fast heartbeat and lasts for quite a while), for Covid-19 immunization, reaction(s): "very fast heartbeat"; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE, She had taken 4 of the 5 Pfizer Covid Vaccines but each time she takes it she gets a very fast heartbeat and lasts for quite a while), for Covid-19 immunization, reaction(s): "very fast heartbeat". The following information was reported: HEART RATE INCREASED (non-serious), outcome "unknown", described as "She had taken 4 of the 5 Pfizer Covid Vaccines but each time she takes it she gets a very fast heartbeat and lasts for quite a while, sometime months". Relevant laboratory tests and procedures are available in the appropriate section.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300352464 Same patient/vaccine/event, different dose.;US-PFIZER INC-202300352449 Same patient/vaccine/event, different dose.;US-PFIZER INC-202300352465 Same patient/vaccine/event, different dose.;
Systemic: stiffness in the arm-Mild, Additional Details: pt, he claims after getting the vaccine his arm is a little stiff. No other adverse reaction seen but pt experienced stiffness in the arm
Caller reports she was coughing the morning of the shot before she got the shot, then felt the overwhelming need to cough all day after the shot, reports she has a hx of anxiety and anxiety causes her to have a 'tickle' in her throat and makes her cough. Caller reports that this evening she felt like she was running a fever but did not take her temperature and now has body aches and feels like she is coming down with something, has been having some OTC cough syrup with good effects.
Within 2 hours swelling in mucosa of mouth similar to the feeling of getting a novacaine injection in mouth. One hour later swelling in area above eye. Took Benadryl which resolved mouth issue but eye swelling persisted for longer.
The patient received her 2nd dose of Moderna COVID vaccine on 8/17/2021 at around 11AM. The patient called us the following day on 8/18/2021 to let us know she was having arm pain and swelling. The patient stated that the symptoms were not immediate and began on the evening of 8/17/2021. We asked the patient if she had tried anything to help her with side effects. The patient said that she had not taken or tried anything at the time of her phone call. We counseled the patient to use a cold compress, ice packs, and/or analgesic medications to help her with the pain and swelling. The patient did not mention needing to seek any additional medical attention.